AdvanDx raises $12mln for expansion
AdvanDx has closed a $12 million financing led by Merck Global Health Innovation Fund with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx's molecular diagnostic product offerings, as well as its sales and marketing presence in the US and internationally.
9 April 2014•2 mins read
